ScoutQuest5 Oct 2026
Bacil Pharma524516Earnings release date

Board meeting on 14 October 2026 to consider and approve unaudited results for the quarter and half year ended 30 September 2026

The Board of Directors is scheduled to meet on Wednesday, 14th October, 2026.

Board Meeting Date
Wednesday, 14th October, 2026
Agenda Item
to consider and approve the Unaudited Financial Results for the half yearly and quarter ended 30th September, 2026
Period Covered
half yearly and quarter ended 30th September, 2026

Advance notice of a Board meeting

The company has told the exchange that its Board of Directors will meet on Wednesday, 14th October, 2026. This is an intimation of the meeting date and agenda, sent ahead of the meeting itself.

What the Board will take up

What this means for a reader

When a company schedules a Board meeting to approve quarterly and half-yearly results, it marks a fixed date on the calendar for those results to be signed off. Until the meeting happens and the results are shared, there is no financial performance data in this intimation to look at. The numbers for the quarter and half year ended 30th September, 2026 would follow separately once the Board has considered and approved them.

Point to note

The item listed is the half yearly and quarter ended 30th September, 2026 results. The meeting notice also leaves room for any other business with the permission of the Chairperson, which is a standard line and does not specify what that business might be.

Source: BSE · 5 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.